SyAllgen (Syntrion GmbH)


Welcome to the PulseAid listing for the SyAllgen drug offered from Syntrion GmbH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Syntrion GmbH
NON-PROPRIETARY NAME: Penicillium Glabrum
SUBSTANCE NAME: PENICILLIUM GLABRUM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: NASAL
DOSAGE FORM: SPRAY
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2011-02-25
END MARKETING DATE: 2018-01-31


SyAllgen HUMAN OTC DRUG Details:

Item DescriptionSyAllgen from Syntrion GmbH
LABELER NAME: Syntrion GmbH
DEA SCHEDULE:
ACTIVE STRENGTH: 6([hp_X]/20mL)
START MARKETING DATE: 2011-02-25
END MARKETING DATE: 2018-01-31
PRODUCT ID: 10424-146_43df8239-ea51-4b1c-bbd5-a664d290cfb2
PRODUCT NDC: 10424-146
APPLICATION NUMBER:

Other PENICILLIUM GLABRUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
sanPharma GmbHQuentaSAN
Sanum Kehlbeck GmbH & Co. KGPleo Quent
SymbiopathicSYMBIO QUENT DROPS
Syntrion GmbHSyAllgen
USPharmaCoQuentans